Mesa Labs Reports First Quarter Results Executive Commentary, August 6, 2020 – Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the first quarter (“1Q21”). Financial highlights for the quarter ended June 30, 2020 as compared to last year: • Revenues increased 14% • Operating income decreased 41% • Non-GAAP adjusted operating income1 excluding unusual items…
DetailsLakewood, Colorado, July 6, 2020 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa Labs” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on September 15, 2020, to shareholders of record at the close of…
DetailsSource: Mesa Laboratories, Inc. – June 16, 2020 11:30 AM ET Lakewood, Colo., June 16, 2020 (GLOBE NEWSWIRE) — Mesa Laboratories, Inc. (NASDAQ: MLAB) (“Mesa Labs”) today announced that the underwriters for its previously announced public offering of common stock have fully exercised their option to purchase 90,000 additional shares of Mesa Labs common stock.…
DetailsSource: Mesa Laboratories, Inc. – June 9, 2020 8:15 PM ET Lakewood, Colo., June 09, 2020 (GLOBE NEWSWIRE) — Mesa Laboratories, Inc. (NASDAQ: MLAB) (“Mesa Labs”) today announced the pricing of an underwritten public offering of 600,000 shares of its common stock at a public offering price of $225.00 per share for gross proceeds of…
DetailsSource: Mesa Laboratories, Inc. – June 8, 2020 4:01 PM ET LAKEWOOD, Colo., June 08, 2020 (GLOBE NEWSWIRE) — Mesa Laboratories, Inc. (NASDAQ: MLAB) (“Mesa Labs”) today announced that it has commenced an underwritten public offering of $100 million of shares of its common stock. In addition, Mesa Labs expects to grant the underwriters a…
DetailsLakewood, Colorado, June 1, 2020 – Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the fourth quarter (“4Q20”) and full year ended March 31, 2020 (“FY20”). Financial highlights for the quarter and year ended March 31, 2020 as compared to last year: • Revenues increased 29% and 14%, respectively • Operating income decreased 65% and…
DetailsLakewood, Colorado, May 15, 2020 – Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced the election of Shannon Hall to its Board of Directors. Shannon previously led the Life Sciences business at Bio-Rad Laboratories. Ms. Hall’s election fills the open position created by the retirement of Robert Dwyer, a position he held for 14 years. In addition,…
DetailsLakewood, Colorado, April 1, 2020 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on June 15, 2020, to shareholders of record at the close of business…
DetailsLakewood, Colorado, February 10, 2020 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, or “Mesa Labs”) today reported third quarter results for the three months ended December 31, 2019. Financial Results (amounts in thousands, except per share data) In comparison to the same quarter in the prior year, third quarter revenues increased 19% to $31,655,…
DetailsLakewood, Colorado, January 9, 2020 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on March 16, 2020, to shareholders of record at the close of business…
Details
